Skip to Content
Author: The BCW

Leave a Comment

Regeneron Gets FDA Approval for EYLEA’s Pediatric Treatment

In another breakthrough for BCW Member Regeneron Pharmaceuticals, the U.S. Food and Drug Administration (FDA) has approved the company’s EYLEA® (aflibercept) Injection to treat preterm infants with retinopathy of prematurity (ROP). Following this first pediatric approval, EYLEA is now indicated to treat five retinal conditions caused by ocular angiogenesis.

“Retinopathy of prematurity is a leading cause of childhood blindness worldwide. Until now, the only FDA-approved treatment in common use was laser photocoagulation, a complex and lengthy procedure that permanently ablates retina tissue and is stressful not only for infant patients but also the family navigating a delicate time after a preterm birth,” said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron, and a principal inventor of EYLEA. “For the first time, physicians will now have an FDA approved medication in EYLEA to treat this heartbreaking disease in these smallest of patients. We thank the investigators and the many families who participated in the clinical trials.”

Each year in the U.S., between 1,100 to 1,500 infants develop ROP that is severe enough to require medical treatment. This rare eye disease often impacts infants who are born before 31 weeks of pregnancy have been completed or who weigh less than 3.3 lbs pounds at birth. “Regeneron’s trials investigating EYLEA in retinopathy of prematurity have advanced our understanding of how to treat this disease and provided a needed evidence-based treatment option to potentially help preterm infants preserve their vision,” said Jeff Todd, Chief Executive Officer of Prevent Blindness.

EYLEA is being jointly developed by Regeneron and Bayer.

Similar News Items

The Business Council of Westchester’s Valley Bank Leadership Conversations welcomed New York Senate Majority Leader Andrea Stewart-Cousins on Thursday to share insights into her career and personal journey. Marsha Gordon, the BCW’s president and CEO, moderated the conversation at Kanopi in White Plains, where Stewart-Cousins recounted her diverse career path, including roles in customer service, […]

Read Article

If there is one subject virtually all business leaders agree on, it is that New York State’s energy landscape is changing. The challenge is that the paths forward are numerous, confusing and often are at odds with the practical realities of implementation costs and technological challenges. The Business Council of Westchester has spent the last […]

Read Article

The Business Council of Westchester’s Westchester Innovation Network (WIN) continues its mission of fostering innovation by facilitating a match between former WPHS graduate and recent Sacred Heart University graduate Michael Berlingo and seasoned executive coach Sunni Lampasso. This collaboration brings together the youthful energy and vision of Berlingo, CEO of Starteryou, with the wisdom and […]

Read Article

Become A Member

Join the county’s largest and most influential business organization today.

JOIN NOW!
The Business Council of Westchester is committed to helping businesses market, learn, advocate, and grow. Over 80 events and programs are offered every year, giving our members ample opportunity to connect and meet with businesses representatives in the Westchester community and beyond.
Back to top